Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases.
Calcium-channel blockers have long been employed in coronary disease, and recent investigations have indicated their efficacy in improving the visual field in low-tension glaucoma or presumed vasospasm, possibly by enhancing ocular circulation. We evaluated the short-term influence of a typical calcium-channel blocker, nifedipine, on 59 patients with visual-field defects, some with optic-nerve-head pathology (n = 38) and some with normal-appearing optic nerve heads (n = 21). On the average, a statistically significant improvement of 1.2 dB was observed. Different types of patients, however, behaved quite differently. The younger the patient, the greater the improvement. Patients with normal optic nerve heads improved by 1.54 dB, whereas patients with optic-nerve-head excavation improved by only 0.66 dB. No response was observed in patients with anterior ischemic neuropathy. Marked deterioration was noted in one glaucoma patient with low systemic blood pressure. The visual-field changes were observed in the scotomatous and non-scotomatous areas. Thus, the calcium-channel blocker nifedipine can be effective in some selected diseases whose pathogenesis probably involves vascular dysregulation though it may even be contraindicated in others.
University Eye Clinic, Basel, Switzerland.
A Z
AZ
Gaspar
J
J
Flammer
P
P
Hendrickson
D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use*; D009898:Optic Disk; D009901:Optic Nerve Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014786:Vision Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014794:Visual Fields / Q000187:drug effects*
D009543:Nifedipine